The FDA announced on 2013-12-16 that Qualitest Pharmaceuticals is recalling Cetirizine Hydrochloride Syrup due to failed impurity specifications for 4-chlorobenzophenone, according to the CPSC.
How to tell if you have it
- Brand: Qualitest Pharmaceuticals
- Product: Cetirizine Hydrochloride Syrup (Cetirizine Hydrochloride Oral Solution, USP) 1 mg/mL
- Sizes: 120 mL and 480 mL bottles
- NDCs: 0603-9063-54 (120 mL), 0603-9063-58 (480 mL)
- Lot Numbers (120 mL): L081K12A, L082K12A, L062M12A, L063M12A, L064M12A, L054A13A, L055A13A, L057A13A, L058A13A, L075B13A, L076B13A, L003C13A, L004C13A, L005C13A
- Lot Numbers (480 mL): L081K12B, L082K12B, L059A13A, L114E13A, L026G13A, L081J13A
- Distribution: Nationwide and Puerto Rico
The hazard
The product is out of specification for the known impurity 4-chlorobenzophenone due to failed degradation specifications, according to the CPSC.
Context
GovInfoNow's records show Qualitest Pharmaceuticals has 12 other recalls on record since 2013-04-19. Other recent recalls of similar products include JB Chemicals Recalls Cetirizine Tablets Due to Cross-Contamination (2026-06-24), Unichem Bisoprolol/Hydrochlorothiazide Tablets Recall: N-Nitroso Impurity Risk (2026-01-21), and QuVa Pharma Recalls Methohexital Sodium Due to Impurity Failures (2026-06-24).